Validation of Peptest (TM) in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing

Creative Commons License

BOR S., Capanoglu D., VARDAR R., Woodcock A. D., Fisher J., Dettmar P. W.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, cilt.28, sa.4, ss.383-387, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.15403/jgld-335
  • Dergi Adı: JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.383-387
  • Anahtar Kelimeler: gastro-esophageal reflux disease, laryngopharyngeal reflux, multichannel intraluminal impedance, pepsin, Peptest (TM), NORMAL VALUES, PEPSIN, PH, RELIABILITY, VALIDITY, DIAGNOSIS, SYMPTOMS, SALIVA
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Hayır

Özet

Background & Aims: Pepsin in the gastric refluxate is a marker for a prior reflux event and rapid detection might be achieved using the Peptest (TM), an in vitro diagnostic medical device. The aim of this study was to validate the use of Peptest (TM) to reliably diagnose reflux in patients with gastro-esophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR) disease diagnosed with multichannel intraluminal impedance/pHmetry (MII-pH).